International Clinical Trial: A study in healthy volunteers to assess how the test medicine (IB1001) affects how the body takes up Digoxin and Rosuvastatin (Part 1) and how food affects blood levels of IB1001 (Part 2)

Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ISRCTN14080958) titled 'A study in healthy volunteers to assess how the test medicine (IB1001) affects how the body takes up Digoxin and Rosuvastatin (Part 1) and how food affects blood levels of IB1001 (Part 2)' on May 15.

Study Type: Interventional

Study Design: Two-part open-label part-randomized study (Other, Safety)

Primary Sponsor: IntraBio Inc.

Condition: Niemann-Pick disease, GM2 gangliosidosis and ataxia telangiectasia Nervous System Diseases

Intervention: This is a two-part study. Part 1 is a two-period, open-label, non-randomised study. Part 2 is an open-label, part-randomised, two-way crossover study. It is planned to e...